Gaby
A new development by the team at the University of California, Los Angeles (USA) will help reduce the costs of diagnosing this severe neurological disease. Parkinson’s disease – the second most common neurodegenerative disease after Alzheimer’s disease Alzheimer’s Currently, 10 million people worldwide suffer from Parkinson’s disease.
The diagnostic device can distinguish between individuals with this disease and those without based on their writing style. Key symptoms of the illness include tremors, as well as deterioration in the movement of limbs and the body.
Why is this invention important?
The diagnosis of Parkinson’s disease, which typically involves observing the patient’s motor skills, remains inaccessible in low- and middle-income countries due to a lack of medical professionals.
Soon, a pen with the potential to assist public health may arrive. artificial intelligence that contains magnetic ink. It detects signs of Parkinson’s disease by analyzing handwriting samples, the publication reported. Independent .
Handwriting is a complex process that requires coordination between the brain and the hands. Previous studies have shown that Parkinson’s disease significantly affects this process.
“We have developed a pen for the autonomous diagnosis of Parkinson’s disease with a soft magnetoelastic tip and ferromagnetic inks, which can sensitively and quantitatively convert movements during writing on surfaces and in the air into high-precision electrical signals that can be analyzed,” the researchers reported.
The team demonstrated that with the help of the AI system, the pen easily distinguished handwriting samples from three patients with Parkinson’s disease from the handwriting samples of 13 healthy participants.
Scientists have found that the device can diagnose Parkinson’s disease in patients with an accuracy of over 95 percent. Researchers hope that the pen will prove to be an affordable, accurate, and widespread technology that will improve the diagnosis of Parkinson’s disease among large populations and in areas where there is a shortage of qualified medical professionals.
The team also noted that this invention is particularly useful in the case of “untreated individuals who have not yet been identified as patients with Parkinson’s disease.”
